Last update 26 Dec 2024
CMAB-807X
Last update 26 Dec 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms CMAB 807X, CMAB-807X, CMAB807X |
Target |
Mechanism RANKL inhibitors(Tumor necrosis factor ligand superfamily member 11 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with CMAB-807XA Randomized, Double-blind, Parallel Controlled, Phase I Three-arm Study, Comparing the PK, PD, Safety, and Immunogenicity of Pre- and Post-change CMAB807X, Post-change CMAB807X and Xgeva® in Healthy Chinese Male Subjects
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of CMAB807X injection versus Angarvir in a single dose of Chinese adult healthy male subjects: a randomized, double-blind, parallel-controlled, phase I study
100 Clinical Results associated with CMAB-807X
Login to view more data
100 Translational Medicine associated with CMAB-807X
Login to view more data
100 Patents (Medical) associated with CMAB-807X
Login to view more data
100 Deals associated with CMAB-807X
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bone metastases | IND Approval | CN | 12 Jan 2022 | |
| Bone metastases | IND Approval | CN | 12 Jan 2022 | |
| Giant Cell Tumor of Bone | IND Approval | CN | 12 Jan 2022 | |
| Giant Cell Tumor of Bone | IND Approval | CN | 12 Jan 2022 | |
| Multiple Myeloma | IND Approval | CN | 12 Jan 2022 | |
| Multiple Myeloma | IND Approval | CN | 12 Jan 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free